Kam‐Ming Ko

1.4k total citations · 1 hit paper
36 papers, 1.1k citations indexed

About

Kam‐Ming Ko is a scholar working on Molecular Biology, Pharmacology and Plant Science. According to data from OpenAlex, Kam‐Ming Ko has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Pharmacology and 7 papers in Plant Science. Recurrent topics in Kam‐Ming Ko's work include Plant-derived Lignans Synthesis and Bioactivity (11 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Kam‐Ming Ko is often cited by papers focused on Plant-derived Lignans Synthesis and Bioactivity (11 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Kam‐Ming Ko collaborates with scholars based in Hong Kong, China and United States. Kam‐Ming Ko's co-authors include Zhi‐Ling Yu, Si-Yuan Pan, Siu‐Po Ip, Shu-Feng Zhou, Minke Tang, Gao S, Gerhard Litscher, Chun‐Tao Che, Sam-Hip Tsai and Shuofeng Zhang and has published in prestigious journals such as Molecules, Critical Reviews in Food Science and Nutrition and Journal of Ethnopharmacology.

In The Last Decade

Kam‐Ming Ko

36 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Historical Perspective of Traditional Indigenous Medical Practices: The Current Renaissance and Conservation of Herbal Resources

2014 347 citations Si-Yuan Pan, Gerhard Litscher et al. Evidence-based Complementary and Alternative Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kam‐Ming Ko Hong Kong	15	431	240	230	219	133	36	1.1k
Ismail O. Ishola Nigeria	23	426 1.0×	165 0.7×	395 1.7×	320 1.5×	212 1.6×	100	1.4k
Kuan‐Hung Lu Taiwan	21	421 1.0×	187 0.8×	294 1.3×	141 0.6×	271 2.0×	43	1.1k
Akbar Anaeigoudari Iran	21	238 0.6×	174 0.7×	126 0.5×	277 1.3×	138 1.0×	61	1.1k
Bosai He China	21	598 1.4×	165 0.7×	185 0.8×	178 0.8×	112 0.8×	54	1.1k
Enbo Cai China	20	479 1.1×	222 0.9×	167 0.7×	98 0.4×	113 0.8×	56	942
Archana R. Juvekar India	20	334 0.8×	228 0.9×	410 1.8×	237 1.1×	152 1.1×	65	1.5k
Eshvendar Reddy Kasala India	18	551 1.3×	106 0.4×	156 0.7×	102 0.5×	231 1.7×	21	1.3k
Chandana Choudhury Barua India	17	492 1.1×	132 0.6×	267 1.2×	149 0.7×	187 1.4×	52	1.2k
Lakshmi Narendra Bodduluru India	17	538 1.2×	101 0.4×	155 0.7×	102 0.5×	230 1.7×	19	1.3k
Bun Tsoi China	22	491 1.1×	99 0.4×	98 0.4×	141 0.6×	144 1.1×	42	1.3k

Countries citing papers authored by Kam‐Ming Ko

Since Specialization

Citations

This map shows the geographic impact of Kam‐Ming Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kam‐Ming Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kam‐Ming Ko more than expected).

Fields of papers citing papers by Kam‐Ming Ko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kam‐Ming Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kam‐Ming Ko. The network helps show where Kam‐Ming Ko may publish in the future.

Co-authorship network of co-authors of Kam‐Ming Ko

This figure shows the co-authorship network connecting the top 25 collaborators of Kam‐Ming Ko. A scholar is included among the top collaborators of Kam‐Ming Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kam‐Ming Ko. Kam‐Ming Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yi, Jing Zhao, Shu-Feng Zhou, et al.. (2017). Biochemical mechanism underlying hypertriglyceridemia and hepatic steatosis/hepatomegaly induced by acute schisandrin B treatment in mice. Lipids in Health and Disease. 16(1). 8–8. 6 indexed citations

Yu, Zhi‐Ling, Si-Yuan Pan, Xiaoyan Wang, et al.. (2015). A comparative study between Wuweizi seed and its post-ethanol extraction residue in normal and hypercholesterolemic mice. Lipids in Health and Disease. 14(1). 93–93. 8 indexed citations

Zhou, Shu‐Feng, Yi Zhang, Zhiwei Zhou, et al.. (2015). Schisandrin B inhibits cell growth and induces cellular apoptosis and autophagy in mouse hepatocytes and macrophages: implications for its hepatotoxicity. Drug Design Development and Therapy. 9. 2001–2001. 23 indexed citations

Pan, Si-Yuan, Peili Zhu, Shu‐Feng Zhou, et al.. (2015). Effects of combined dietary supplementation with fenofibrate and Schisandrae Fructus pulp on lipid and glucose levels and liver function in normal and hypercholesterolemic mice. Drug Design Development and Therapy. 9. 923–923. 10 indexed citations

Wang, Xiaoyan, Zhi‐Ling Yu, Si-Yuan Pan, et al.. (2014). Supplementation with the Extract of Schisandrae Fructus Pulp, Seed, or Their Combination Influences the Metabolism of Lipids and Glucose in Mice Fed with Normal and Hypercholesterolemic Diet. Evidence-based Complementary and Alternative Medicine. 2014(1). 472638–472638. 11 indexed citations

Pan, Si-Yuan, Yi Zhang, Shufeng Zhou, et al.. (2014). Time and dose relationships between schisandrin B- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in mice. Drug Design Development and Therapy. 8. 1429–1429. 11 indexed citations

Pan, Si-Yuan, et al.. (2014). Traditional Medicines in the World: Where to Go Next?. Evidence-based Complementary and Alternative Medicine. 2014(1). 739895–739895. 34 indexed citations

Pan, Si-Yuan, Gao S, Rui‐Chao Lin, et al.. (2013). New Perspectives on Dietary-derived Treatments and Food Safety—Antinomy in a New Era. Critical Reviews in Food Science and Nutrition. 55(13). 1836–1859. 3 indexed citations

Pan, Si-Yuan, Yi Zhang, Qing Yu, et al.. (2013). A Novel Mouse Model of Combined Hyperlipidemia Associated With Steatosis and Liver Injury by a Single-Dose Intragastric Administration of Schisandrin B/Cholesterol/Bile Salts Mixture. Journal of Pharmacological Sciences. 123(2). 110–119. 13 indexed citations

10.

Pan, Si-Yuan, Qing Yu, Yi Zhang, et al.. (2012). Dietary Fructus Schisandrae extracts and fenofibrate regulate the serum/hepatic lipid-profile in normal and hypercholesterolemic mice, with attention to hepatotoxicity. Lipids in Health and Disease. 11(1). 120–120. 30 indexed citations

11.

Leung, Hoi Yan, Chungwah Ma, Qing Tang, & Kam‐Ming Ko. (2011). Long-Term Treatment with a Compound Polysaccharide-Based Health Product (Infinitus Polysac Plus) Enhances Innate and Adaptive Immunity in Mice. Chinese Medicine. 2(4). 178–185. 3 indexed citations

12.

Chen, Yan, Siu‐Po Ip, Kam‐Ming Ko, et al.. (2010). A Proteomic Approach in Investigating the Hepatoprotective Mechanism of Schisandrin B: Role of Raf Kinase Inhibitor Protein. Journal of Proteome Research. 10(1). 299–304. 10 indexed citations

13.

Chen, Mengli, Siu‐Po Ip, Sam-Hip Tsai, Kam‐Ming Ko, & Chun‐Tao Che. (2010). Biochemical mechanism of Wu-Zi-Yan-Zong-Wan, a traditional Chinese herbal formula, against alcohol-induced oxidative damage in CYP2E1 cDNA-transfected HepG2 (E47) cells. Journal of Ethnopharmacology. 128(1). 116–122. 11 indexed citations

14.

Mao, Qing‐Qiu, Siu‐Po Ip, Kam‐Ming Ko, Sam-Hip Tsai, & Chun‐Tao Che. (2009). Peony glycosides produce antidepressant-like action in mice exposed to chronic unpredictable mild stress: Effects on hypothalamic-pituitary-adrenal function and brain-derived neurotrophic factor. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33(7). 1211–1216. 123 indexed citations

15.

Pan, Si-Yuan, et al.. (2009). Comparison Studies of Tacrine and Bis(7)-Tacrine on the Suppression of Scopolamine-Induced Behavioral Changes and Inhibition of Acetylcholinesterase in Mice. Pharmacology. 83(5). 294–300. 10 indexed citations

16.

Mao, Qing‐Qiu, Siu‐Po Ip, Kam‐Ming Ko, et al.. (2009). Effects of peony glycosides on mice exposed to chronic unpredictable stress: Further evidence for antidepressant-like activity. Journal of Ethnopharmacology. 124(2). 316–320. 54 indexed citations

17.

Leung, Hoi Yan, et al.. (2007). Schisandrin B decreases the sensitivity of mitochondria to calcium ion-induced permeability transition and protects against ischemia-reperfusion injury in rat hearts. Acta Pharmacologica Sinica. 28(10). 1559–1565. 33 indexed citations

18.

Pan, Si-Yuan, Rong Yang, Hang Dong, Zhi‐Ling Yu, & Kam‐Ming Ko. (2006). Bifendate treatment attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet-induced hypercholesterolemia in mice. European Journal of Pharmacology. 552(1-3). 170–175. 50 indexed citations

19.

Ko, Kam‐Ming, et al.. (2001). Schisandrin B modulates the ischemia-reperfusion induced changes in non-enzymatic antioxidant levels in isolated-perfused rat hearts. Molecular and Cellular Biochemistry. 220(1-2). 141–147. 32 indexed citations

20.

Ko, Kam‐Ming, et al.. (1995). Enhancement of Hepatic Glutathione Regeneration Capacity by a Lignan-Enriched Extract of Fructus Schisandrae in Rats. The Japanese Journal of Pharmacology. 69(4). 439–442. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact